Hematology laboratory shift based on common terminology criteria in patients with advanced basal cell carcinoma receiving sonidegib 200 mg daily: Results from the 42-month BOLT study. J of Skin. 2023;7(2):s180. doi:10.25251/skin.7.supp.180